Mod GRF 1-29
Sermorelin, Growth Hormone Releasing Hormone (1-29), hGRF(1-29)NH2
A synthetic peptide analog of growth hormone-releasing hormone that stimulates the pituitary gland to secrete growth hormone.
Withdrawn
NCT01788462
Egrifta Replacement and Sleep Disordered Breathing
Johns Hopkins University
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
NCT00006073
Endocrine Studies in Health and Disease
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01359488
VRS-317 in Adult Subjects With Growth Hormone Deficiency
Versartis Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT01088412
Observational Study of Somatropin Treatment in Children
Eli Lilly and Company
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01419197
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Hoffmann-La Roche
INTERVENTIONAL
Updated Dec 15, 2025